Prime Medicine Q3 2026 net loss narrows 23% to $39 million year over year
Prime Medicine Q3 2026 net loss narrows 23% to $39 million year over year Prime Medicine’s third
Prime Medicine Q3 2026 net loss narrows 23% to $39 million year over year Prime Medicine’s third